• AMAYA, F., OH-HASHI, K., NARUSE, Y., IIJIMA, N., UEDA, M., SHIMOSATO, G., TOMINAGA, M., TANAKA, Y. & TANAKA, M. (2003). Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res., 963, 190196.
  • BISOGNO, T., HANUS, L., DE PETROCELLIS, L., TCHILIBON, S., PONDE, D.E., BRANDI, I., SCHIANO MORIELLO, A., DAVIS, J.V., MECHOULAM, R. & DI MARZO, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol., 134, 845852.
  • CALIGNANO, A., LA RANA, G., GIUFFRIDA, A. & PIOMELLI, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394, 277281.
  • CARLTON, S.M. & COGGESHALL, R.E. (2001). Peripheral capsaicin receptors increase in the inflamed hindpaw: a possible mechanism for peripheral sensitisation. Neurosci. Lett., 310, 5356.
  • CARTA, G., GESSA, G.L. & NAVA, F. (1999). Dopamine D2 receptor antagonists prevent Δ9-tetrahydrocannabinol-induced antinociception in rats. Eur. J. Pharmacol., 384, 153156.
  • CATERINA, M.J., LEFFLER, A., MALMBERG, A.B., MARTIN, W.J., TRAFTON, J., PETERSEN-ZEITZ, K.R., KOLTZENBURG, M., BASBAUM, A.I. & JULIUS, D. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306313.
  • COSTA, B., COLLEONI, M., CONTI, S., PAROLARO, D., FRANKE, C., TROVATO, A.E. & GIAGNONI, G. (2004). Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch. Pharmacol., 369, 294299.
  • DAVIS, J.B., GRAY, J., GUNTHORPE, M.J., HATCHER, J.P., DAVEY, P.T., OVEREND, P., HARRIES, M.H., LATCHAM, J., CLAPHAM, C., ATKINSON, K., HUGHES, S.A., RANCE, K., GRAU, E., HARPER, A.J., PUGH, P.L., ROGERS, D.C., BINGHAM, S., RANDALL, A. & SHEARDOWN, S.A. (2000). Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 405, 183187.
  • DI MARZO, V., LASTRES-BECKER, I., BISOGNO, T., DE PETROCELLIS, L., MILONE, A., DAVIS, J.B. & FERNANDEZ-RUIZ, J.J. (2001). Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol., 420, 123131.
  • HARGREAVES, K.M., DUBNER, R., BROWN, S., FLORES, C. & JORIS, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 7788.
  • MALFAIT, A.M., GALLILY, R., SUMARIWALLA, P.F., MALIK, A.S., ANDREAKOS, E., MECHOULAM, R. & FELDMANN, M. (2000). The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U.S.A., 97, 95619566.
  • MECHOULAM, R., PARKER, L.A. & GALLILY, R. (2002). Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol., 42, 11S19S.
  • PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129180.
  • RAKHSHAN, F., DAY, T.A., BLAKELY, R.D. & BARKER, E.L. (2000). Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther., 124, 315322.
  • RASHID, M.H., INOUE, M., BAKOSHI, S. & UEDA, H. (2003). Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J. Pharmacol. Exp. Ther., 306, 709717.
  • RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J-M, CASELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIERE, J-C & Le FUR, G. (1998). SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644650.
  • WATANABE, K., KAYANO, Y., MATSUNAGA, T., YAMAMOTO, I. & YOSHIMURA, H. (1996). Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol. Pharm. Bull., 19, 11091111.
  • ZIMMERMANN, M. (1983). Ethical guidelines for investigation of experimental pain in conscious animals. Pain, 16, 109110.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.